These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19375272)

  • 21. Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006.
    Boudal P; Sommet A; Bagheri H; Pathak A; Montastruc JL
    Therapie; 2010; 65(6):567-9. PubMed ID: 21176763
    [No Abstract]   [Full Text] [Related]  

  • 22. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
    Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
    Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticoagulant treatment with fluindione. Relation between the decrease of vitamin K-dependent factors and blood fluindione].
    Roncato M; Billaud-Mesguich E; Fiessinger JN; Vitoux JF; Aiach M; Alexandre JM
    Therapie; 1986; 41(3):203-6. PubMed ID: 3750259
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rebuttal: vitamin K antagonists and cancer survival.
    Zacharski LR; Henderson WG
    Thromb Haemost; 2002 Jul; 88(1):173-4; author reply 175. PubMed ID: 12152670
    [No Abstract]   [Full Text] [Related]  

  • 26. [Necrotic leg ulcers induced by vitamin K antagonists: five cases].
    Bezier M; Perceau G; Reguiai Z; Remy-Leroux V; Tchen T; Durlach A; Grange F; Nguyen P; Bernard P
    Ann Dermatol Venereol; 2011 Oct; 138(10):657-63. PubMed ID: 21978501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between amiodarone and vitamin K antagonists.
    Prescrire Int; 2003 Apr; 12(64):64. PubMed ID: 12674126
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunoallergic adverse effects of fluindione.
    Prescrire Int; 2010 Nov; 19(110):255-6. PubMed ID: 21284358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preventive anticoagulant treatment in surgery. Indications--technics].
    Nicolas F
    Anesth Analg (Paris); 1967; 24(5):497-505. PubMed ID: 5593939
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramural hemorrhage of small intestine due to anticoagulants.
    Killian ST; Heitzman EJ
    JAMA; 1967 May; 200(7):591-4. PubMed ID: 5297869
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
    Schulman S
    N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
    [No Abstract]   [Full Text] [Related]  

  • 33. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summaries for patients. Rivaroxaban in patients transitioned from vitamin K antagonist therapy.
    Ann Intern Med; 2013 Jun; 158(12):I-28. PubMed ID: 23778921
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute interstitial nephritis of fluindione: about three cases].
    Beauchamp C; Enache I; Haskour A; Martin L
    Nephrol Ther; 2008 Oct; 4(5):339-46. PubMed ID: 18417438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vitamin K antagonists and platelet aggregation inhibitors in the prevention of thrombosis].
    Moriau M; Ferrant A
    Acta Clin Belg; 1977; 32(6):409-21. PubMed ID: 616752
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prospective study of oral anticoagulation control in 110 very elderly hospitalized patients and of risk factors for poor control].
    Vogel T; Coriol V; Kaltenbach G; Kiesmann M; Berthel M
    Presse Med; 2008 Dec; 37(12):1723-30. PubMed ID: 18644323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists.
    Chatrou ML; Winckers K; Hackeng TM; Reutelingsperger CP; Schurgers LJ
    Blood Rev; 2012 Jul; 26(4):155-66. PubMed ID: 22520397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.